Compare HBM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBM | BIO |
|---|---|---|
| Founded | 1927 | 1952 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 8.7B |
| IPO Year | N/A | N/A |
| Metric | HBM | BIO |
|---|---|---|
| Price | $24.69 | $313.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $21.25 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 4.1M | 185.7K |
| Earning Date | 02-20-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.06% | N/A |
| EPS Growth | ★ 396.15 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | $2,063,000,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $10.83 | $1.62 |
| Revenue Next Year | $12.19 | $2.26 |
| P/E Ratio | $19.38 | ★ N/A |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $5.95 | $211.43 |
| 52 Week High | $23.34 | $373.69 |
| Indicator | HBM | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 80.17 | 48.29 |
| Support Level | $22.02 | $316.57 |
| Resistance Level | $23.20 | $328.56 |
| Average True Range (ATR) | 0.82 | 8.90 |
| MACD | 0.19 | 0.09 |
| Stochastic Oscillator | 97.66 | 44.32 |
Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.